Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 17901 - 17925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	CCDC137	339230	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCDC137 mRNA	17q25.3	A21749
Copper	Approved Investigational	CCDC141	285025	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCDC141 mRNA	2q31.2	A21749
Copper	Approved Investigational	CCDC34	91057	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCDC34 mRNA	11p14.1	A21749
Copper	Approved Investigational	CCDC58	131076	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CCDC58 mRNA	3q21.1	A21750
Copper	Approved Investigational	CCDC59	29080	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CCDC59 mRNA	12q21.31	A21750
Copper	Approved Investigational	CCDC80	151887	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CCDC80 mRNA	3q13.2	A21749
Copper	Approved Investigational	CCDC85C	317762	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCDC85C mRNA	14q32.2	A21749
Copper	Approved Investigational	CCDC92	80212	upregulated	[Disulfiram binds to Copper] which results in increased expression of CCDC92 mRNA	12q24.31	A21750
Copper	Approved Investigational	CCDC94	55702	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CCDC94 mRNA	19p13.3	A21750
Copper	Approved Investigational	CCK	885	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CCK mRNA	3p22.1	A21750
Copper	Approved Investigational	CCL2	6347	upregulated	[Disulfiram binds to Copper] which results in increased expression of CCL2 mRNA	17q12	A21750
Copper	Approved Investigational	CCL26	10344	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CCL26 mRNA	7q11.23	A21750
Copper	Approved Investigational	CCL26	10344	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CCL26 mRNA	7q11.23	A21749
Copper	Approved Investigational	CCL5	6352	upregulated	[Disulfiram binds to Copper] which results in increased expression of CCL5 mRNA	17q12	A21750
Copper	Approved Investigational	CCNA2	890	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCNA2 mRNA	4q27	A21749
Copper	Approved Investigational	CCNB1	891	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCNB1 mRNA	5q13.2	A21749
Copper	Approved Investigational	CCNB2	9133	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCNB2 mRNA	15q22.2	A21749
Copper	Approved Investigational	CCNF	899	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCNF mRNA	16p13.3	A21749
Copper	Approved Investigational	CCNK	8812	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CCNK mRNA	14q32.2	A21750
Copper	Approved Investigational	CCNL2	81669	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CCNL2 mRNA	1p36.33	A21749
Copper	Approved Investigational	CCP110	9738	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CCP110 mRNA	16p12.3	A21749
Copper	Approved Investigational	CCPG1	9236	upregulated	[Disulfiram binds to Copper] which results in increased expression of CCPG1 mRNA	15q21.3	A21750
Copper	Approved Investigational	CCPG1	9236	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CCPG1 mRNA	15q21.3	A21749
Copper	Approved Investigational	CD302	9936	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CD302 mRNA	2q24.2	A21749
Copper	Approved Investigational	CD320	51293	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CD320 mRNA	19p13.2	A21749

Displaying entries 17901 - 17925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability